The Alpex Solar IPO received an overwhelming response from investors. On the final day of bidding, the IPO garnered a staggering 324 times subscription. The Alpex Solar IPO allotment status is set to be finalised today.

If you applied for the IPO, here is how you can check the Alpex Solar IPO allotment status.

Checking IPO Allotment Status on Registrar's Website:

Follow these steps to check the Alpex Solar IPO allotment status

1. Visit the registrar's website.
2. Click on "Company Selection" and choose "Alpex Solar" from the dropdown menu.
3. Then you can enter your PAN, application number, or Demat.
4. Enter the captcha and click Submit to retrieve the Alpex Solar IPO allotment status

If all the details are entered correctly and the allotment has been finalised, the Alpex Solar IPO allotment status will be visible.

See Also: Railway Stocks Continue To Bleed, But Analyst Suggests Holding These 2 Stocks

Alpex Solar IPO Subscription Status

With an IPO size of ₹74.52 crore, Alpex Solar’s public subscription commenced on Thursday, February 8. The retail category saw a subscription of 351.89 times, while the non-institutional quota recorded a subscription of 502.31 times. The Qualified Institutional Buyer (QIB) category received 141.48 times subscription. Bids were received for around 139 crore shares, surpassing the 43 lakh shares on offer.

Alpex Solar IPO Details

The IPO comprises entirely fresh issue shares totalling 64.8 lakh shares, with a price band set at ₹109 to ₹115 per share. Established in August 1993, Alpex Solar Limited specializes in manufacturing solar panels, utilizing both monocrystalline and polycrystalline cell technologies. The company’s clientele includes prominent entities such as Solarworld Energy Solutions Pvt Ltd, BVG India Limited, Tata Power, Hild Energy Private Limited, and Shakti Pumps India Limited.

Alpex Solar IPO GMP

While the Alpex Solar IPO noticed a decline to ₹150 from ₹190, it suggests a potential listing at ₹265, reflecting a premium of around 130%. It’s essential to note that while GMPs can offer insights into market sentiment, they should not be the sole determinant of the stock’s performance upon listing.

Read Next: This Small Cap Stock Has Surged 100% In 1 Year, Analysts See Further 57% Upside